Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.

British journal of haematology - 1 Jul 2000

de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H

Abstract excerpt

We determined the prevalence of factor V Leiden and of prothrombin G20210A mutations in a cohort of unselected outpatients (n = 748) referred for suspected deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and a pooled analysis of similar studies was also performed. Based on the clinical presentation, the prevalence of factor V Leiden was 15.7% in the 83 patients with DVT and 14.1% in the 99 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Odds Ratio

Share to Prevalence

Share to Prothrombin

Share to Pulmonary Embolism

Share to Thromboembolism

Source

Identifiers

PMID: 10930988
DOI: 10.1046/j.1365-2141.2000.02039.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.PMID 10930988Read ↗

Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.Semantic proximity Read ↗

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.Semantic proximity Read ↗

Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous ThromboembolismSemantic proximity Read ↗

Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.Semantic proximity Read ↗

Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.Semantic proximity Read ↗

Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.Semantic proximity Read ↗

Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature.Semantic proximity Read ↗

A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.Semantic proximity Read ↗

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.Semantic proximity Read ↗

Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.Semantic proximity Read ↗

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.Semantic proximity Read ↗

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.